These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22610724)

  • 41. Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.
    Defesche JC; Pricker KL; Hayden MR; van der Ende BE; Kastelein JJ
    Arch Intern Med; 1993 Oct; 153(20):2349-56. PubMed ID: 8215738
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre.
    Gray J; Jaiyeola A; Whiting M; Modell M; Wierzbicki AS
    Heart; 2008 Jun; 94(6):754-8. PubMed ID: 17575326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial hypercholesterolemia: experience from France.
    Rabès JP; Béliard S; Carrié A
    Curr Opin Lipidol; 2018 Apr; 29(2):65-71. PubMed ID: 29389714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis.
    Beeharry D; Coupe B; Benbow EW; Morgan J; Kwok S; Charlton-Menys V; France M; Durrington PN
    Ann Rheum Dis; 2006 Mar; 65(3):312-5. PubMed ID: 16176995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial hypercholesterolaemia: optimum treatment strategies.
    Ballantyne CM
    Int J Clin Pract Suppl; 2002 Jul; (130):22-6. PubMed ID: 12296605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autosomal dominant hypercholesterolemia in Catalonia: Correspondence between clinical-biochemical and genetic diagnostics in 967 patients studied in a multicenter clinical setting.
    Martín-Campos JM; Plana N; Figueras R; Ibarretxe D; Caixàs A; Esteve E; Pérez A; Bueno M; Mauri M; Roig R; Martínez S; Pintó X; Masana L; Julve J; Blanco-Vaca F;
    J Clin Lipidol; 2018; 12(6):1452-1462. PubMed ID: 30293936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
    Kawashiri MA; Nohara A; Noguchi T; Tada H; Nakanishi C; Mori M; Konno T; Hayashi K; Fujino N; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
    Am J Cardiol; 2012 Feb; 109(3):364-9. PubMed ID: 22112743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.
    Rallidis LS; Triantafyllis AS; Tsirebolos G; Katsaras D; Rallidi M; Moutsatsou P; Lekakis J
    Atherosclerosis; 2016 Jun; 249():17-21. PubMed ID: 27062405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak K; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    J Clin Lipidol; 2013; 7(3):217-21. PubMed ID: 23725921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LDL-receptor mutations in Europe.
    Dedoussis GV; Schmidt H; Genschel J
    Hum Mutat; 2004 Dec; 24(6):443-59. PubMed ID: 15523646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular basis of familial hypercholesterolemia in The Netherlands.
    Fouchier SW; Defesche JC; Umans-Eckenhausen MW; Kastelein JP
    Hum Genet; 2001 Dec; 109(6):602-15. PubMed ID: 11810272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors.
    Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž
    Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.
    Raal FJ; Pilcher GJ; Panz VR; van Deventer HE; Brice BC; Blom DJ; Marais AD
    Circulation; 2011 Nov; 124(20):2202-7. PubMed ID: 21986285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia.
    Leitersdorf E; Eisenberg S; Eliav O; Friedlander Y; Berkman N; Dann EJ; Landsberger D; Sehayek E; Meiner V; Wurm M
    Circulation; 1993 Apr; 87(4 Suppl):III35-44. PubMed ID: 8462179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heterozygous familial hypercholesterolemia case study.
    Friedrich DA
    J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia.
    Brusgaard K; Jordan P; Hansen H; Hansen AB; Hørder M
    Clin Genet; 2006 Mar; 69(3):277-83. PubMed ID: 16542394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.